Diclofenamide is a sulfonamide carbonic anhydrase inhibitor belonging to the meta-disulfamoylbenzene class, primarily used in the management of glaucoma to reduce intraocular pressure and in the treatment… Read more
Diclofenamide is a sulfonamide carbonic anhydrase inhibitor belonging to the meta-disulfamoylbenzene class, primarily used in the management of glaucoma to reduce intraocular pressure and in the treatment of primary hypokalemic and hyperkalemic periodic paralysis. In pharmaceutical research and manufacturing, precise analytical tools are essential for maintaining rigorous safety and efficacy standards. This category provides high-quality reference standards for diclofenamide API, which are vital for laboratories performing impurity profiling, method validation, and quality control. Researchers can also access pharmacopeial and non-pharmacopeial impurities, such as 1,1- and 1,3-dichlorphenamide dimers, to support comprehensive stability testing. Additionally, the availability of stable isotope-labelled compounds enables accurate quantification in complex matrices during metabolic studies and pharmacokinetic analysis. These products ensure that developers and analytical chemists have the reliable materials required to meet regulatory compliance and support drug development processes throughout the product lifecycle.